AMAIA
ARRUABARRENA ARISTORENA
INVESTIGADOR/A DOCTOR/A
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (8)
2022
-
PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer
Oncogenesis, Vol. 11, Núm. 1
2018
-
Low-dose statin treatment increases prostate cancer aggressiveness
Oncotarget, Vol. 9, Núm. 2, pp. 1494-1504
-
PPARd elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth
Cancer Research, Vol. 78, Núm. 2, pp. 399-409
2017
-
MTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer
Nature, Vol. 547, Núm. 7661, pp. 109-113
2016
-
Stratification and therapeutic potential of PML in metastatic breast cancer
Nature Communications, Vol. 7
-
The metabolic co-regulator PGC1α suppresses prostate cancer metastasis
Nature Cell Biology, Vol. 18, Núm. 6, pp. 645-656
-
Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer
Oncotarget, Vol. 7, Núm. 6, pp. 6835-6846
2015
-
Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN
Methods, Vol. 77, pp. 25-30